{"basics":{"name":"Ahmet Ozan ÖZGEN","label":"Pharm. (MSc)","image":"","email":"ozan_ozgen@outlook.com","phone":"","url":"https://pharmozgen.me","summary":"Experienced clinical research professional with expertise in BE/BA studies, clinical trials, and regulatory compliance. Strong skills in stakeholder management, contract negotiation, and portfolio oversight. Leverages data science and programming to drive innovative solutions in pharmaceutical research.","location":{"address":"Ümraniye","postalCode":"34764","city":"Istanbul","countryCode":"TR","region":"Turkiye"},"profiles":[{"network":"LinkedIn","username":"719101","url":"https://www.linkedin.com/in/719101/"}]},"work":[{"name":"Nobel İlaç","position":"Clinical Research Specialist","url":"https://www.nobel.com.tr/","startDate":"Apr. 2023","endDate":"Current","summary":["Nobel, as a pharmaceutical company, operates with five manufacturing facilities, three in Turkiye and one in Kazakhstan and Uzbekistan, while carrying out promotion and sales activities with its organizations in 20 countries, and through distributors in 30 countries. In my role, I contribute to preclinical and clinical activities, ensuring strict compliance with R&D timelines and product launches. Additionally, I manage responses to regulatory queries and deficiencies for regulatory submissions in over 50 countries. Key achievements include:<br>","- Negotiated contracts with over 10 CROs across Europe, the USA, and India while establishing partnerships with various service vendors.<br>","- Prepared clinical and non-clinical modules (CTD) for more than 30 medicinal products including biosimilars. Conducted preliminary research for more than 25 projects (generics & biosimilars).<br>","- Integrated IMP procurement and regulatory affairs requests into an online platform. Also, Developed RPA software with a vendor to track study timelines, and EC/MoH applications.<br>","- Monitoring visits to two clinical trials and fifteen BE studies in Turkiye. Also, site qualification audits to four sites in Turkiye and six in India.<br>","- Accountable person for organizing pharmacovigilance activities within clinical trials.<br>","- Successfully processed over 30 inquiries and deficiencies from regulatory authorities. Also, assisted in preparing CAPA for a BfArM site audit for a BE project.<br>","- Organized and facilitated four investigator meetings."],"highlights":["Clinical Trials","Regulatory Compliance","Pharmacovigilance","CRO Management","HCP Engagement","Contracts"]},{"name":"Biocalis","position":"Business Development Executive","url":"https://www.biocalis.com/","startDate":"June 2020","endDate":"Apr. 2023","summary":["Biocalis is a healthcare company specializing in in-vitro diagnostics, medical devices and pharmaceuticals and leverages a wide distribution network spanning over 25 countries. In my role, I collaborated with an international team and managed accounts in EMEA and Central Asia, coordinating the eﬀorts of our oﬃces in Albania, Azerbaijan, Uzbekistan, and Russia while reporting directly to the managing director. I utilized HubSpot CRM and Excel to analyze performance metrics and track account activities. Key contributions include:<br>","- Conducted market research for a partner (in-vitro diagnostics) to identify potential biomarkers of interest to CDMOs CROs, and other research organizations, followed by lead generation through Springer's AdisInsight subscription.<br>","- Initiated outbound lead generation for PCR Kits during the COVID-19 pandemic, successfully adding new accounts in Croatia, Romania, the UAE, and Pakistan. These accounts also began distributing our other in-vitro diagnostics.<br>","- Identiﬁed a critical gap in the Albanian market and proposed adding cefuroxime to our Albanian portfolio to address the demand for secondary bacterial infection prevention in COVID-19 patients. Coordinated its registration process and signiﬁcantly increased our revenue during the pandemic.<br>","- Found and integrated an AI-powered 3D/4D aesthetic simulation software into our plastic surgery portfolio and supported over 20 plastic surgeons with product training and sales strategies.<br>","- Created and delivered many materials (educational & promotional) to HCPs and patients in Turkiye, enhancing the reach of our Allurion intragastrical balloon to over 3000 patients."],"highlights":["Regulatory Strategy","Out-Licensing","Negotiation","Market Research","Lead Generation","Account Management"]},{"name":"Avaroğlu Pharmacy","position":"Retail Pharmacist","startDate":"Aug. 2019","endDate":"June 2020","summary":["I was responsible for coordinating safe and effective medication therapy for patients. Also, I had to adapt the everyday routine of the personnel to conditions caused by the COVID-19 pandemic."],"highlights":["Patient Counseling","Polypharmacy Management","Pharmacy Operations","COVID-19"]}],"volunteer":[{"organization":"Istanbul Chamber of Pharmacists","location":"Istanbul, Turkiye","position":"Youth Assembly and Assistant Pharmacists Commission Member","url":"https://www.istanbuleczaciodasi.org.tr/","startDate":"Oct. 2019","endDate":"Aug. 2023","summary":"Our projects focused on the sustainable development goals of the UN and their adaptation to pharmacists in general. I have also volunteered for a week in one of the field pharmacies (Antakya, Turkiye) after the 6 February 2023 earthquakes.","highlights":["NGO","Pharmacy Disaster Management"]},{"organization":"Istanbul Chamber of Pharmacists, Youth Assembly","location":"Istanbul, Turkiye","position":"Youth Delegate","url":"http://ieogm.org/","startDate":"Oct. 2017","endDate":"Oct. 2019","summary":"Youth Delegate IEO Youth Assembly is an autonomous structure where pharmacy students and pharmacists take place and produce together. I had been selected as a delegate in an election that took place in my faculty. I represented my faculty for 2 years and served in many projects. We have organized the first (2018) and the second (2019) pharmacist youth meetings.","highlights":["Event Coordination"]}],"education":[{"institution":"Istanbul Medipol University","location":"Istanbul, Turkiye","url":"https://www.medipol.edu.tr/","area":"Pharmacy","studyType":"BSc","startDate":"2014","endDate":"2019","score":"2.95/4.0"},{"institution":"Akdeniz University","location":"Antalya, Türkiye","url":"https://www.akdeniz.edu.tr/","area":"Medical Biotechnology","studyType":"MSc","startDate":"2021","endDate":"2023","score":"4.0/4.0","courses":["Bioinformatics","Machine Learning"]},{"institution":"Akdeniz University","location":"Antalya, Türkiye","url":"https://www.akdeniz.edu.tr/","area":"Gene and Cell Therapy","studyType":"PhD","startDate":"2024","endDate":"2030","score":"Completed the course period"}],"awards":[{"title":"Honor Reward","date":"May 2023","awarder":"Istanbul Chamber of Pharmacists","url":"https://www.pharmetic.org/istanbul-eczaci-odasi-2023-yili-meslek-ici-onur-odulleri","summary":"I have been awarded for my volunteer work in a field pharmacy after the 6 February 2023 earthquakes."},{"title":"Local Competition Winner","date":"July 2022","awarder":"Seeds for the Future (ICT Talent) - Huawei","url":"https://www.huawei.com/en/news/2022/12/european-talent-summit","summary":"As part of Huawei's global Corporate Social Responsibility flagship program; I have been selected for the program in 2022 after several interviews. I have led a team of 10, and we have developed and presented an AI-driven solution to prevent violence toward healthcare workers. We have won the Turkish part in the global competition and participated in the talent summit held in Athens."}],"certificates":[{"name":"GCP Training","date":"2023","issuer":"Turkish Clinical Research Association","url":"/assets/img/gcp-training_2023.png","icon":"fa-solid fa-location-dot"},{"name":"Quantum Computing","date":"2018-01-01","issuer":"Stanford University","url":"https://example.com","icon":"fa-solid fa-tag"},{"name":"Quantum Information","date":"2018-01-01","issuer":"Stanford University","url":"https://example.com","icon":"fa-solid fa-envelope"},{"name":"Quantum Cryptography","date":"2018-01-01","issuer":"Stanford University","url":"https://example.com","icon":"fa-solid fa-hashtag"},{"name":"Quantum Communication","date":"2018-01-01","issuer":"Stanford University","url":"https://example.com","icon":"fa-solid fa-calendar"},{"name":"Quantum Teleportation","date":"2018-01-01","issuer":"Stanford University","url":"https://example.com","icon":"fa-solid fa-clipboard-check"}],"publications":[{"name":"Zur Elektrody/namik bewegter Körper","publisher":"Annalen der Physik","releaseDate":"1905-06-30","url":"https://en.wikisource.org/wiki/Translation:On_the_Electrodynamics_of_Moving_Bodies","summary":"It concerned an interpretation of the Michelson–Morley experiment and the properties of light and time. Special relativity incorporates the principle that the speed of light is the same for all inertial observers regardless of the state of motion of the source."},{"name":"Über einen die Erzeugung und Verwandlung des Lichtes betreffenden heuristischen Gesichtspunkt","publisher":"Annalen der Physik","releaseDate":"1905-03-18","url":"https://de.wikisource.org/wiki/Über_einen_die_Erzeugung_und_Verwandlung_des_Lichtes_betreffenden_heuristischen_Gesichtspunkt","summary":"In the second paper, he applied the quantum theory to light to explain the photoelectric effect. In particular, he used the idea of light quanta (photons) to explain experimental results, but stressed the importance of the experimental results. The importance of his work on the photoelectric effect earned him the Nobel Prize in Physics in 1921."},{"name":"Die Grundlage der allgemeinen Relativitätstheorie","publisher":"Annalen der Physik","releaseDate":"1916-03-20","url":"https://de.wikisource.org/wiki/Die_Grundlage_der_allgemeinen_Relativitätstheorie","summary":"The publication of the theory of general relativity made him internationally famous. He was professor of physics at the universities of Zurich (1909–1911) and Prague (1911–1912), before he returned to ETH Zurich (1912–1914)."}],"skills":[{"name":"Physics","level":"Master","icon":"fa-solid fa-hashtag","keywords":["Quantum Mechanics","Quantum Computing","Quantum Information","Quantum Cryptography","Quantum Communication","Quantum Teleportation"]}],"languages":[{"language":"Turkish","fluency":"Native language","icon":""},{"language":"English","fluency":"Full professional proficiency (IELTS: 7.5 | eYDS: 92.5)","icon":""}],"interests":[{"name":"Physics","icon":"fa-solid fa-tag","keywords":["Quantum Mechanics","Quantum Computing","Quantum Information","Quantum Cryptography","Quantum Communication","Quantum Teleportation"]}],"references":[{"name":"Professor John Doe","icon":"fa-solid fa-laptop","reference":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam condimentum, diam quis convallis euismod, arcu mi ullamcorper lorem, a vestibulum nunc magna at sem. Sed in risus ac felis varius blandit. D"},{"name":"Professor John Doe","icon":"fa-solid fa-thumbtack","reference":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam condimentum, diam quis convallis euismod, arcu mi ullamcorper lorem, a vestibulum nunc magna at sem. Sed in risus ac felis varius blandit. D"}],"projects":[{"name":"Quantum Computing","summary":"Quantum computing is the use of quantum-mechanical phenomena such as superposition and entanglement to perform computation. Computers that perform quantum computations are known as quantum computers.","highlights":["Quantum Teleportation","Quantum Cryptography"],"startDate":"2018-01-01","endDate":"2018-01-01","url":"https://example.com"},{"name":"Clinical Trial Management Platform","summary":"Developed an online platform integrating IMP procurement and regulatory affairs requests. Built RPA software to track study timelines and manage EC/MoH applications for clinical trials and BE studies.","highlights":["RPA","Clinical Trials","Regulatory Compliance"],"startDate":"2023-01-01","endDate":"2023-12-31","url":"https://example.com/clinical-platform"}]}